Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-21
2007-08-21
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S235000
Reexamination Certificate
active
11168622
ABSTRACT:
The invention is concerned with novel hexafluoroisopropanol derivatives of formula (I)wherein R1to R6, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to LXR alpha and LXR beta and can be used as medicaments.
REFERENCES:
patent: WO 03/090732 (2003-11-01), None
patent: WO 03/099769 (2003-12-01), None
Willy et al., Genes Dev. 1995, 9:1033-45.
Song et al., Proc Natl Acad Sci USA.1994, 91:10809-13.
Miller NE., Lipids 1978,13:914-9.
Gordon et al., Am J Med. 1977, 62:707-14.
Lund et al., A{grave over (r)}terioscler. Thromb. Vasc. Biol. 2003, 23:1169-77.
Joseph and Tontonoz, Curr. Opin. Pharmacol. 2003, 3:192-7.
Cao et al., J Biol Chem. 2003, 278:1131-6.
Dehmlow Henrietta
Kuhn Bernd
Masciadri Raffaello
Panday Narendra
Ratni Hasane
Grazier Nyeemah
Hoffmann-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Saeed Kamal A.
LandOfFree
Hexafluoroisopropanol derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hexafluoroisopropanol derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hexafluoroisopropanol derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3900174